Display Settings:

Format

Send to:

Choose Destination
    Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. Epub 2007 Dec 14.

    Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.

    Source

    Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo, 693-8501, Japan. miyanyan@med.shimane-u.ac.jp

    Abstract

    BACKGROUND:

    Recent studies indicate that the traditional Japanese herbal medicine yi-gan san (YGS, yokukan-san in Japanese), a serotonin modulator, may be safe and useful in treating behavioral and psychological symptoms in dementia and borderline personality disorder patients. The authors examined the efficacy, tolerability, and safety of YGS in patients with tardive dyskinesia.

    METHODS:

    Twenty-two patients with schizophrenia who had neuroleptic-induced tardive dyskinesia were given 7.5 g/day of YGS for 12 weeks in an open-label study.

    RESULTS:

    Administration of YGS resulted in a statistically significant improvement in tardive dyskinesia and psychotic symptoms.

    CONCLUSIONS:

    YGS may be an effective and safe therapy to control tardive dyskinesia and psychosis in patients with schizophrenia, that should be further tested in double-blind, placebo-controlled trials.

    PMID:
    18201810
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk